Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06314204

Impact of Cannabis Consumption on the Course, Modalities of Hospitalization and the Short-term Prognosis of Inpatients Suffering From Psychotic Symptoms

Impact of Cannabis Consumption on the Course, Modalities of Hospitalization and the Short-term Prognosis of Inpatients Suffering From Psychotic Symptoms : Multicenter Comparative Observational Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Centre hospitalier de Ville-Evrard, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Few studies have evaluated, in patients with symptomatology the impact of cannabis use on the duration of hospitalization and on short- and medium-term developments. The objective of this study will be to assess the impact of cannabis on the duration, the hospitalization and the short- and medium-term evolution of patients with psychotic symptoms and cannabis use. We hypothesize that these patients (in comparison with patients with psychotic symptomatology and not using cannabis) would be hospitalized more long, exposed to a higher risk of resistance to the usual therapeutics, would have a lack of therapeutic alliance and insight, relapses and hospitalizations more frequent, more marked negative symptoms and lower quality remission. They would also be more prone to impulsive and aggressive behaviour.

Detailed description

Several studies have reported that cannabis use worsen the prognosis of psychiatric pathologies in general and psychotic in particular. Few or no studies have evaluated the impact of cannabis consumption on patients with psychotic symptoms during their hospitalization (duration, type of hospitalization, quality of relationship with staff hospital), and on the short-term prognosis. The objective of this study will be to assess the impact of cannabis on the duration of the hospitalization and the short- and medium-term evolution of patients with a psychotic symptomatology and cannabis use. Making the hypothesis that these patients (compared to patients with symptomatology psychotic and not using cannabis) would be hospitalized longer, exposed at a higher risk of resistance to the usual therapies, to have a lack of alliance therapeutic and insight, relapses and more frequent hospitalizations and symptoms. They would also be more likely to have lower quality. They would also be more likely to be impulsive, and have aggressive behaviours.

Conditions

Timeline

Start date
2016-09-20
Primary completion
2025-09-06
Completion
2026-09-06
First posted
2024-03-15
Last updated
2024-03-15

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06314204. Inclusion in this directory is not an endorsement.